Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004626345 | SCV005121065 | uncertain significance | Inborn genetic diseases | 2024-05-12 | criteria provided, single submitter | clinical testing | The c.3560G>A (p.R1187Q) alteration is located in exon 29 (coding exon 29) of the IFT122 gene. This alteration results from a G to A substitution at nucleotide position 3560, causing the arginine (R) at amino acid position 1187 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005023608 | SCV005661427 | uncertain significance | Cranioectodermal dysplasia 1 | 2024-05-17 | criteria provided, single submitter | clinical testing |